Skip to content
Catalyst

PapersPMID:37880041

Methylene Blue Reduces Mortality in Critically Ill and Perioperative Patients: A Meta-Analysis of Randomized Trials.

Journal of cardiothoracic and vascular anesthesia2024The record ↗

  1. Finding, very limited evidencelowersAll-cause mortality

What moved

1 findingHow to read these marks →
  • Decreases all-cause mortality

    very limitedreplicated ×2

    “Nine out of the 11 included randomized trials reported mortality, which was significantly lower in the MB group (risk ratio, 0.60 [95% CI 0.43-0.84] p = 0.003), with findings confirmed in septic shock and cardiac surgery subgroups.”
    Study
    meta-analysis
    Population
    critically ill and perioperative adult patients; mortality at longest follow-up, pooled across randomized trials

Study record

Design
meta-analysis
Species
human
Population
Critically ill and perioperative patients with vasodilatory hypotension; 11 randomized trials of methylene blue
Participants
556
Comparator
not stated in the paper
Duration
not reported
Endpoints measured
8
Declined
another reason, stated per paper